These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22658411)

  • 1. Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition.
    Yadav UC; Srivastava SK; Ramana KV
    J Diabetes Complications; 2012; 26(5):369-77. PubMed ID: 22658411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.
    Obrosova IG; Minchenko AG; Vasupuram R; White L; Abatan OI; Kumagai AK; Frank RN; Stevens MJ
    Diabetes; 2003 Mar; 52(3):864-71. PubMed ID: 12606532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.
    Tammali R; Saxena A; Srivastava SK; Ramana KV
    J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo.
    Tammali R; Reddy AB; Srivastava SK; Ramana KV
    Angiogenesis; 2011 May; 14(2):209-21. PubMed ID: 21409599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
    Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
    Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis.
    Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L
    Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aldose reductase prevents colon cancer metastasis.
    Tammali R; Reddy AB; Saxena A; Rychahou PG; Evers BM; Qiu S; Awasthi S; Ramana KV; Srivastava SK
    Carcinogenesis; 2011 Aug; 32(8):1259-67. PubMed ID: 21642355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
    Drel VR; Pacher P; Ali TK; Shin J; Julius U; El-Remessy AB; Obrosova IG
    Int J Mol Med; 2008 Jun; 21(6):667-76. PubMed ID: 18506358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
    Hattori T; Matsubara A; Taniguchi K; Ogura Y
    Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.
    Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S
    Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.
    Chang KC; Ponder J; Labarbera DV; Petrash JM
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2853-61. PubMed ID: 24677107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway.
    Pal PB; Sonowal H; Shukla K; Srivastava SK; Ramana KV
    J Mol Endocrinol; 2019 Jul; 63(1):11-25. PubMed ID: 30986766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice.
    Yadav UC; Naura AS; Aguilera-Aguirre L; Boldogh I; Boulares HA; Calhoun WJ; Ramana KV; Srivastava SK
    PLoS One; 2013; 8(2):e57442. PubMed ID: 23460857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between aldose reductase enzyme and the signaling pathway of protein kinase C in an in vitro diabetic retinopathy model.
    Sarikaya M; Yazihan N; Daş Evcimen N
    Can J Physiol Pharmacol; 2020 Apr; 98(4):243-251. PubMed ID: 31743046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol.
    Sampath C; Sang S; Ahmedna M
    Biomed Pharmacother; 2016 Dec; 84():502-513. PubMed ID: 27685794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
    Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
    Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.
    Obrosova IG; Maksimchyk Y; Pacher P; Agardh E; Smith ML; El-Remessy AB; Agardh CD
    Int J Mol Med; 2010 Jul; 26(1):135-42. PubMed ID: 20514433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells.
    Ramana KV; Bhatnagar A; Srivastava SK
    FASEB J; 2004 Aug; 18(11):1209-18. PubMed ID: 15284221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmotic expression of aldose reductase in retinal pigment epithelial cells: involvement of NFAT5.
    Winges A; Garcia TB; Prager P; Wiedemann P; Kohen L; Bringmann A; Hollborn M
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2387-2400. PubMed ID: 27628063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase inhibitor ameliorates renal vascular endothelial growth factor expression in streptozotocin-induced diabetic rats.
    Sung JK; Koh JH; Lee MY; Kim BH; Nam SM; Kim JH; Yoo JH; Kim SH; Hong SW; Lee EY; Choi R; Chung CH
    Yonsei Med J; 2010 May; 51(3):385-91. PubMed ID: 20376891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.